Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Developing Quality Programs for Cell-Free DNA (cfDNA) Extraction from Peripheral Blood.

The journal of applied laboratory medicine - 1 Jul 2020

Samoila Aliaksandra, Sosa Jose, Padilla Jessica, Wutkowski Michael, Vanness Katelynd, Viale Agnes, Berger Michael, Houck-Loomis Brian, Pessin Melissa, Peerschke Ellinor I

Abstract excerpt

BACKGROUND: Cell-free DNA (cfDNA) analysis using peripheral blood represents an exciting, minimally invasive technology for cancer diagnosis and monitoring. The reliability of testing is dependent on the accuracy and sensitivity of specific molecular analyses to detect tumor-associated genomic variants and on the quantity and quality of cfDNA available for testing. Specific guidelines for standardization and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Specimen Collection
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to Guidelines as Topic

Share to Mutation

Share to Neoplasms

Share to Quality Control

Share to Reproducibility of Results

Source

Identifiers

PMID: 32603443
DOI: 10.1093/jalm/jfaa050

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Developing Quality Programs for Cell-Free DNA (cfDNA) Extraction from Peripheral Blood.PMID 32603443Read ↗

Evaluation of automatic cell free DNA extraction metrics using different blood collection tubesSemantic proximity Read ↗

Collection of cell-free DNA for genomic analysis of solid tumors in a clinical laboratory settingSemantic proximity Read ↗

A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.Semantic proximity Read ↗

Circulating free DNA in the era of precision oncology: Pre‐ and post‐analytical concernsSemantic proximity Read ↗

Preanalytical variables that affect the outcome of cell-free DNA measurementsSemantic proximity Read ↗

Towards a Robust cell-free DNA Isolation Protocol for NGS Applications in a Clinical Molecular Diagnostics SettingSemantic proximity Read ↗

Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoringSemantic proximity Read ↗

Evaluation of pre-analytical factors affecting plasma DNA analysisSemantic proximity Read ↗

Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma Samples.Semantic proximity Read ↗

Benchmarking fragmentation-derived artificial cfDNA reference standardsSemantic proximity Read ↗

Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging TechnologiesSemantic proximity Read ↗

Pre-Analytical Evaluation of Streck Cell-Free DNA Blood Collection Tubes for Liquid Profiling in OncologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.